David E. Griffith
Impact in
- Epidemiology top 0.05%
- Mycobacterium research and diagnosis
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
Papers in
- Epidemiology 133
- Mycobacterium research and diagnosis 131
-
- Tuberculosis Research and Epidemiology 28
- Co-authors
- Richard J. Wallace (49 shared papers)Barbara A. Brown‐Elliott (34 shared papers)Charles L. Daley (26 shared papers)Timothy R. Aksamit (25 shared papers)Barbara A. Brown (16 shared papers)Kevin L. Winthrop (27 shared papers)Kenneth N. Olivier (11 shared papers)Stephen J. Ruoss (9 shared papers)
- Journals
- CHEST Journal (26 papers)American Journal of Respiratory and Critical Care Medicine (21 papers)Clinical Infectious Diseases (20 papers)European Respiratory Journal (8 papers)Clinics in Chest Medicine (6 papers)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
David E. Griffith
202 papers receiving 16.1k citations
David E. Griffith's Hit Papers
Peers
Comparison fields: 5 of 132
- Epidemiology 12.4k
- Infectious Diseases 1.7k
- Microbiology 52
- Pulmonary and Respiratory Medicine 1.6k
- Applied Microbiology and Biotechnology 82
Countries citing papers authored by David E. Griffith
This map shows the geographic impact of David E. Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Griffith more than expected).
Fields of papers citing papers by David E. Griffith
This network shows the impact of papers produced by David E. Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Griffith. The network helps show where David E. Griffith may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Griffith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Hit paper breakdown → | 2007 | 4842 |
| 2 | Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Hit paper breakdown → | 2020 | 614 |
| 3 | Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Hit paper breakdown → | 2020 | 606 |
| 4 | Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Hit paper breakdown → | 2020 | 587 |
| 5 | Clinical Features of Pulmonary Disease Caused by Rapidly Growing Mycobacteria: An Analysis of 154 Patients Hit paper breakdown → | 1993 | 434 |
| 6 | Elevated Levels of NAP-1/Interleukin-8 Are Present in the Airspaces of Patients with the Adult Respiratory Distress Syndrome and Are Associated with Increased Mortality Hit paper breakdown → | 1992 | 433 |
| 7 | 1998 | 353 | |
| 8 | Adult Patients With Bronchiectasis Hit paper breakdown → | 2016 | 344 |
| 9 | 2006 | 302 | |
| 10 | 2014 | 292 | |
| 11 | Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study Hit paper breakdown → | 2018 | 275 |
| 12 | 1996 | 224 | |
| 13 | 2018 | 219 | |
| 14 | 2016 | 216 | |
| 15 | 2019 | 216 | |
| 16 | 2015 | 189 | |
| 17 | 2016 | 187 | |
| 18 | 2005 | 176 | |
| 19 | 1994 | 165 | |
| 20 | 2014 | 162 |
About David E. Griffith
David E. Griffith is a scholar working on Epidemiology, Infectious Diseases, Pulmonary and Respiratory Medicine, Immunology and Pharmacology, having authored 207 papers that have together received 16.9k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (131 papers), Tuberculosis Research and Epidemiology (28 papers), Occupational and environmental lung diseases (10 papers), Cystic Fibrosis Research Advances (10 papers), Respiratory Support and Mechanisms (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Epidemiology (12.4k citations), Infectious Diseases (1.7k citations), Microbiology (52 citations), Pulmonary and Respiratory Medicine (1.6k citations) and Applied Microbiology and Biotechnology (82 citations). David E. Griffith has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Richard J. Wallace, Barbara A. Brown‐Elliott, Charles L. Daley, Timothy R. Aksamit, Barbara A. Brown, Kevin L. Winthrop, Kenneth N. Olivier, Stephen J. Ruoss, Antonino Catanzaro and C. Fordham von Reyn. Their work appears in journals such as CHEST Journal, American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases, European Respiratory Journal and Clinics in Chest Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.